Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC TAK-901 934541-31-8 200mg
Supplier: Apexbio Technology LLC A4124200
TAK-901 (CAS 934541-31-8) is a small-molecule inhibitor primarily targeting Aurora B kinase with reported IC50 values of 0 0017 M for Aurora-B/INCENP and 0 021 M for Aurora-A/TPX2 Derived from an azacarboline kinase hinge-binding chemotype TAK-901 demonstrates time-dependent selective inhibition of Aurora B suppressing histone H3 phosphorylation and inducing polyploidy in vitro It inhibits proliferation across a range of human cancer cell lines (40 500 nM) and additionally targets kinases such as FLT3 and FGFR2 in cells In preclinical rodent xenograft models TAK-901 reduces tumor growth and induces complete regression in ovarian cancer models A phase I clinical trial has evaluated its dosing and pharmacokinetic characteristics in patients with advanced solid tumors and lymphomas
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?